Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry 'Revision: v3.6.5' has been added. The 'Investigator Inquiry Form' and the previous 'Revision: v3.6.4' entry have been removed, reflecting administrative updates to the study record rather than changes to trial content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4 to reflect a small backend/template update.SummaryDifference0.0%

- Check47 days agoChange DetectedA new revision tag v3.6.3 is now shown, replacing v3.6.2, signaling a minor update to the page's revision history without substantive changes to the study information.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, reflecting a newer build of the page.SummaryDifference0.0%

- Check61 days agoChange DetectedDeleted the Bristol-Myers Squibb clinical trial educational resource from the Study Details page, removing access to the trial's educational materials.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now clearly indicates that the study is no longer recruiting participants. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading and a site revision tag (Revision: v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.